Skeletal myopathy in heart failure: Effects of aerobic exercise training

Experimental Physiology

Volumn 99, Issue 4, 2014, Pages 616-620

  Brum, P C ^a,b   Bacurau, A V ^a   Cunha, T F ^a   Bechara, L R G ^a   Moreira, J B N ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOETHYLISOTHIOURONIUM; PROTEASOME; UBIQUITIN;

AEROBIC CAPACITY; AEROBIC EXERCISE; ARTICLE; CLINICAL TRIAL (TOPIC); EXERCISE; FUNCTIONAL STATUS; HEART FAILURE; HEART FUNCTION; HUMAN; MUSCLE ATROPHY; MYOPATHY; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PROTEIN DEGRADATION; SKELETAL MUSCLE; SYMPOSIUM; THERAPY EFFECT; ANIMAL; COMPLICATION; CONVALESCENCE; EXERCISE TOLERANCE; HEART MUSCLE; KINESIOTHERAPY; MUSCLE CONTRACTION; MUSCULAR ATROPHY; MUSCULAR DISEASES; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ANIMALS; EXERCISE THERAPY; EXERCISE TOLERANCE; HEART FAILURE; HUMANS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MUSCULAR DISEASES; MYOCARDIUM; OXYGEN CONSUMPTION; RECOVERY OF FUNCTION; TREATMENT OUTCOME;

EID: 84897374200     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2013.076844     Document Type: Article

References (30)

1. Aiken CT, Kaake RM, Wang X & Huang L (2011). Oxidative stress-mediated regulation of proteasome complexes. Mol Cell Proteomics 10, 1-11.
2. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA & Coats AJ (1997). Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349, 1050-1053.
3. Attaix D, Combaret L, Béchet D & Taillandier D (2008). Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia. Curr Opin Support Palliat Care 2, 262-266.
4. Bacurau AV, Jardim MA, Ferreira JC, Bechara LR, Bueno CR Jr, Alba-Loureiro TC, Negrao CE, Casarini DE, Curi R, Ramires PR, Moriscot AS & Brum PC (2009). Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training. J Appl Physiol 106, 1631-1640.
5. Barker T & Traber MG (2007). From animals to humans: evidence linking oxidative stress as a causative factor in muscle atrophy. J Physiol 583, 421-422.
6. Brum PC, Bacurau AV, Medeiros A, Ferreira JC, Vanzelli AS & Negrao CE (2011). Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function. Braz J Med Biol Res 44, 827-835.
7. Brum PC, Kosek J, Patterson A, Bernstein D & Kobilka B (2002). Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol 283, H1838-H1845.
8. 2+ handling-related protein expression in sympathetic hyperactivity-induced heart failure. J Appl Physiol 109, 702-709.
9. Cunha TF, Bacurau AV, Moreira JB, Paixão NA, Campos JC, Ferreira JC, Leal ML, Negrão CE, Moriscot AS, Wisløff U & Brum PC (2012). Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure. PLoS One 7, e41701.
10. Drexler H, Riede U, Münzel T, König H, Funke E & Just H (1992). Alterations of skeletal muscle in chronic heart failure. Circulation 85, 1751-1759.
11. European Society of Cardiology (2001). Recommendations for exercise training in chronic heart failure patients. Eur Heart J 22, 125-135.
12. 2+ handling-related proteins in sympathetic hyperactivity-induced heart failure. Life Sci 88, 578-585.
13. Fraga R, Franco FG, Roveda F, de Matos LN, Braga AM, Rondon MU, Rotta DR, Brum PC, Barretto AC, Middlekauff HR & Negrão CE (2007). Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol. Eur J Heart Fail 9, 630-636.
14. Gielen S, Sandri M, Kozarez I, Kratzsch J, Teupser D, Thiery J, Erbs S, Mangner N, Lenk K, Hambrecht R, Schuler G & Adams V (2012). Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig Exercise Intervention in Chronic Heart Failure and Aging catabolism study. Circulation 125, 2716-2727.
15. Glass DJ (2003). Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 5, 87-90.
16. Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, Möbius-Winkler S, Schubert A, Schuler G & Hambrecht R (2005). Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle. Circulation 111, 1763-1770.
17. Massie BM, Simonini A, Sahgal P, Wells L & Dudley GA (1996). Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. J Am Coll Cardiol 27, 140-145.
18. Middlekauff HR (2010). Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 3, 537-546.
19. Moholdt T, Aamot IL, Granøien I, Gjerde L, Myklebust G, Walderhaug L, Brattbakk L, Hole T, Graven T, Stølen TO, Amundsen BH, Mølmen-Hansen HE, Støylen A, Wisløff U & Slørdahl SA (2012). Aerobic interval training increases peak oxygen uptake more than usual care exercise training in myocardial infarction patients: a randomized controlled study. Clin Rehabil 26, 33-44.
20. Moreira JB, Bechara LR, Bozi LH, Jannig PR, Monteiro AW, Dourado PM, Wisløff U & Brum PC (2013). High- versus moderate-intensity aerobic exercise training effects on skeletal muscle of infarcted rats. J Appl Physiol 114, 1029-1041.
21. Rognmo Ø, Moholdt T, Bakken H, Hole T, Mølstad P, Myhr NE, Grimsmo J & Wisløff U (2012). Cardiovascular risk of high- versus moderate-intensity aerobic exercise in coronary heart disease patients. Circulation 126, 1436-1440.
22. 2+ handling protein expression in heart failure. Physiol Genomics 29, 246-252.
23. Roveda F, Middlekauff HR, Rondon MU, Reis SF, Souza M, Nastari L, Barretto AC, Krieger EM & Negrão CE (2003). The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. J Am Coll Cardiol 42, 854-860.
24. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B & Sandri M (2013). Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 280, 4294-4314.
25. Sullivan MJ, Green HJ & Cobb FR (1990). Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81, 518-527.
26. Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA 3rd, Fulton JE, Gordon NF, Haskell WL, Link MS, Maron BJ, Mittleman MA, Pelliccia A, Wenger NK, Willich SN, Costa F; American Heart Association Council on Nutrition, Physical Activity, and Metabolism; American Heart Association Council on Clinical Cardiology; & American College of Sports Medicine (2007). Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 115, 2358-2368.
27. Vanzelli AS, Medeiros A, Rolim N, Bartholomeu JB, Cunha TF, Bechara LG, Gomes ER, Mattos KC, Sirvente R, Salemi V, Mady C, Negrao CE, Guatimosim S & Brum PC (2013). Integrative effect of carvedilol and aerobic exercise training therapies on improving cardiac contractility and remodeling in heart failure mice. PLoS One 8, e62452.
28. von Haehling S, Steinbeck L, Doehner W, Springer J & Anker SD (2013). Muscle wasting in heart failure: an overview. Int J Biochem Cell Biol 45, 2257-2265.
29. Wisløff U, Støylen A, Loennechen JP, Bruvold M, Rognmo Ø, Haram PM, Tjønna AE, Helgerud J, Slørdahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen Ø & Skjaerpe T (2007). Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115, 3086-3094.
30. Zizola C & Schulze PC (2013). Metabolic and structural impairment of skeletal muscle in heart failure. Heart Fail Rev 18, 623-630.